These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18450430)

  • 21. QEEG Predictors of Treatment Response in Major Depressive Disorder- A Replication Study from Northwest India.
    Singh A; Arun P; Singh GP; Kaur D; Kaur S
    Clin EEG Neurosci; 2024 Mar; 55(2):176-184. PubMed ID: 36448183
    [No Abstract]   [Full Text] [Related]  

  • 22. Subanesthetic dose of ketamine decreases prefrontal theta cordance in healthy volunteers: implications for antidepressant effect.
    Horacek J; Brunovsky M; Novak T; Tislerova B; Palenicek T; Bubenikova-Valesova V; Spaniel F; Koprivova J; Mohr P; Balikova M; Hoschl C
    Psychol Med; 2010 Sep; 40(9):1443-51. PubMed ID: 19995475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
    Wang G; Gislum M; Filippov G; Montgomery S
    Curr Med Res Opin; 2015 Apr; 31(4):785-94. PubMed ID: 25650503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate variability and cordance in rapid eye movement sleep as biomarkers of depression and treatment response.
    Pawlowski MA; Gazea M; Wollweber B; Dresler M; Holsboer F; Keck ME; Steiger A; Adamczyk M; Mikoteit T
    J Psychiatr Res; 2017 Sep; 92():64-73. PubMed ID: 28411417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can prefrontal theta cordance differentiate between depression recovery and dissimulation?
    Kopecek M; Sos P; Brunovsky M; Bares M; Stopkova P; Krajca V
    Neuro Endocrinol Lett; 2007 Aug; 28(4):524-6. PubMed ID: 17693989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A; Roose S
    Am J Geriatr Psychiatry; 2006 Apr; 14(4):361-70. PubMed ID: 16582045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frontal EEG predictors of treatment outcome in major depressive disorder.
    Iosifescu DV; Greenwald S; Devlin P; Mischoulon D; Denninger JW; Alpert JE; Fava M
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):772-7. PubMed ID: 19574030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Brain Functional Changes in High-Frequency Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression.
    Ozekes S; Erguzel T; Sayar GH; Tarhan N
    Clin EEG Neurosci; 2014 Oct; 45(4):257-261. PubMed ID: 24733717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does prior antidepressant treatment of major depression impact brain function during current treatment?
    Hunter AM; Cook IA; Leuchter AF
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):711-20. PubMed ID: 22445212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
    Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
    Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
    Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of venlafaxine in major depression resistant to selective serotonin reuptake inhibitors.
    Sáiz-Ruiz J; Ibáñez A; Díaz-Marsá M; Arias F; Padín J; Martín-Carrasco M; Montes JM; Ferrando L; Carrasco JL; Martín-Ballesteros E; Jordá L; Chamorro L
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1129-34. PubMed ID: 12452535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ; Ventura D; Chang CC
    J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study.
    Baskaran A; Farzan F; Milev R; Brenner CA; Alturi S; Pat McAndrews M; Blier P; Evans K; Foster JA; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Strother SC; Turecki G; Kennedy SH;
    J Affect Disord; 2018 Feb; 227():542-549. PubMed ID: 29169123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder.
    Bares M; Novak T; Brunovsky M; Kopecek M; Höschl C
    J Nerv Ment Dis; 2017 Aug; 205(8):618-626. PubMed ID: 27660994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study.
    Cook IA; Leuchter AF; Morgan ML; Stubbeman W; Siegman B; Abrams M
    J Psychiatr Res; 2005 Sep; 39(5):461-6. PubMed ID: 15992554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA; Andersen HF
    Int Clin Psychopharmacol; 2006 Sep; 21(5):297-309. PubMed ID: 16877901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.